An open label clinical trial to evaluate the Efficacy of Kuka Cough Syrup in the Patients Suffering with Kasa (Acute Cough and Throat Irritation)

Multani Pharmaceuticals Ltd0 个研究点目标入组 46 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•History of acute nonproductive cough due to any cause.
•Subjects who are willing to give informed consent and ready to comply with the protocol.
•Subjects who are ready to provide regular follow up until the completion of the study.

•Participants with a history of acute lower respiratory tract infections such as pneumonia, bronchitis whooping cough, chronic obstructive pulmonary disease/asthma, tuberculosis, systemic bacterial infections for which specific drug therapy required Any underlying lung pathology such as lung abscess or cystic fibrosis, individuals with a history of myocardial infarction within 4 weeks prior to enrollment;

发起方

Multani Pharmaceuticals Ltd